logo
Plus   Neg
Share
Email

PDL BioPharma Decides To Pursue Monetization Of Its Assets - Quick Facts

PDL BioPharma, Inc. (PDLI) has decided to pursue a formal process to unlock value by monetizing the company's assets and returning net proceeds to shareholders. The decision followed the the strategic review process that it initiated in September.

PDL will explore a variety of potential transactions, including a sale of the company, divestiture of its assets or businesses, a spin-off transaction, a merger or a combination. The company has decided to halt the execution of its growth strategy, and cease additional strategic investments.

Also, PDL's Board has authorized the repurchase of issued and outstanding shares of the company's common stock and convertible notes up to an aggregate value of $200 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Online-video streaming giant Netflix Inc. (NFLX), Tuesday reported a fourth-quarter profit that trounced Wall Street estimates, as revenues surged 31% driven by strong subscriber growth. Netflix added 8.76 million subscribers globally in the quarter, above its forecast of 7.60 million, to end the... Fast food chain Krystal Company has filed for bankruptcy, according to reports. The Atlanta-based Krystal filed for Chapter 11 on Sunday in the U.S. Bankruptcy Court in Atlanta. In the filing, the company reportedly disclosed assets between $10 million and $50 million, and liabilities between $50 million and $100 million. The chief executive officer of Google's parent company Alphabet called for artificial intelligence or AI to be regulated, noting that there are real concerns about the potential negative consequences of the technology. According to Alphabet CEO Sundar Pichai, there are real concerns about the negative consequences of AI, from deepfakes to nefarious uses of facial recognition.
RELATED NEWS
Follow RTT
>